These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 37066112)
1. Gene Screening in High-Throughput Right-Censored Lung Cancer Data. Ke C; Bandyopadhyay D; Acunzo M; Winn R Onco (Basel); 2022 Dec; 2(4):305-318. PubMed ID: 37066112 [TBL] [Abstract][Full Text] [Related]
2. Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genes. Diao X; Guo C; Liu L; Wang G; Li S Thorac Cancer; 2021 Dec; 12(23):3236-3247. PubMed ID: 34672420 [TBL] [Abstract][Full Text] [Related]
3. Tumor mutation burden (TMB)-associated signature constructed to predict survival of lung squamous cell carcinoma patients. Yan D; Chen Y Sci Rep; 2021 Apr; 11(1):9020. PubMed ID: 33907270 [TBL] [Abstract][Full Text] [Related]
4. A Novel Immune-Related Seventeen-Gene Signature for Predicting Early Stage Lung Squamous Cell Carcinoma Prognosis. Fan T; Lu Z; Liu Y; Wang L; Tian H; Zheng Y; Zheng B; Xue L; Tan F; Xue Q; Gao S; Li C; He J Front Immunol; 2021; 12():665407. PubMed ID: 34177903 [TBL] [Abstract][Full Text] [Related]
5. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients. Wang K; Li Y; Wang J; Chen R; Li J Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782 [TBL] [Abstract][Full Text] [Related]
6. Urmi AF; Ke C; Bandyopadhyay D medRxiv; 2024 Aug; ():. PubMed ID: 39185537 [TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Four-Gene Ferroptosis Signature for Predicting Overall Survival of Lung Squamous Cell Carcinoma. Wang Q; Chen Y; Gao W; Feng H; Zhang B; Wang H; Lu H; Tan Y; Dong Y; Xu M Front Oncol; 2022; 12():933925. PubMed ID: 35912252 [TBL] [Abstract][Full Text] [Related]
8. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Squamous Carcinoma. Zhai WY; Duan FF; Chen S; Wang JY; Zhao ZR; Wang YZ; Rao BY; Lin YB; Long H Front Cell Dev Biol; 2022; 10():770550. PubMed ID: 35300428 [TBL] [Abstract][Full Text] [Related]
9. A glycolysis-based three-gene signature predicts survival in patients with lung squamous cell carcinoma. Huang G; Zhang J; Gong L; Huang Y; Liu D BMC Cancer; 2021 May; 21(1):626. PubMed ID: 34044809 [TBL] [Abstract][Full Text] [Related]
10. Identification of an Innate Immune-Related Prognostic Signature in Early-Stage Lung Squamous Cell Carcinoma. Li L; Yu X; Ma G; Ji Z; Bao S; He X; Song L; Yu Y; Shi M; Liu X Int J Gen Med; 2021; 14():9007-9022. PubMed ID: 34876838 [TBL] [Abstract][Full Text] [Related]
11. Development and validation of a novel immune-related prognostic signature in lung squamous cell carcinoma patients. Liu X; Zhao D; Shan Y; Cui W; Xie Q; Jiang J; Peng W; Zhang C; Duan C Sci Rep; 2022 Dec; 12(1):20737. PubMed ID: 36456645 [TBL] [Abstract][Full Text] [Related]
12. Risk stratification and prognosis prediction based on inflammation-related gene signature in lung squamous carcinoma. Zhai W; Chen S; Duan F; Wang J; Zhao Z; Lin Y; Rao B; Wang Y; Zheng L; Long H Cancer Med; 2023 Feb; 12(4):4968-4980. PubMed ID: 36056909 [TBL] [Abstract][Full Text] [Related]
13. Development of an autophagy-related gene prognostic signature in lung adenocarcinoma and lung squamous cell carcinoma. Zhu J; Wang M; Hu D PeerJ; 2020; 8():e8288. PubMed ID: 31938577 [TBL] [Abstract][Full Text] [Related]
14. A prognostic 11-DNA methylation signature for lung squamous cell carcinoma. Zhang J; Luo L; Dong J; Liu M; Zhai D; Huang D; Ling L; Jia X; Luo K; Zheng G J Thorac Dis; 2020 May; 12(5):2569-2582. PubMed ID: 32642165 [TBL] [Abstract][Full Text] [Related]
15. A Novel Prognosis Signature Based on Ferroptosis-Related Gene DNA Methylation Data for Lung Squamous Cell Carcinoma. Wang X; Meng Y; Liu C; Yang H; Zhou S J Oncol; 2022; 2022():9103259. PubMed ID: 36131791 [TBL] [Abstract][Full Text] [Related]
16. A 13-gene signature to predict the prognosis and immunotherapy responses of lung squamous cell carcinoma. Yang Q; Gong H; Liu J; Ye M; Zou W; Li H Sci Rep; 2022 Aug; 12(1):13646. PubMed ID: 35953696 [TBL] [Abstract][Full Text] [Related]
17. Construction and Validation of Prognostic Regulation Network Based on RNA-Binding Protein Genes in Lung Squamous Cell Carcinoma. Zhao S; Liu Q; Li J; Hu C; Cao F; Ma W; Gao J DNA Cell Biol; 2021 Dec; 40(12):1563-1583. PubMed ID: 34931870 [TBL] [Abstract][Full Text] [Related]
18. A Hypoxia-Related Signature for Predicting Prognosis, Cellular Processes, Immune Microenvironment and Targeted Compounds in Lung Squamous Cell Carcinoma. Wu G; Zhu Z; Yang Z; He M; Ren K; Dong Y; Xue Q Int J Gen Med; 2022; 15():3991-4006. PubMed ID: 35437352 [TBL] [Abstract][Full Text] [Related]
19. A Combined RNA Signature Predicts Recurrence Risk of Stage I-IIIA Lung Squamous Cell Carcinoma. Sun L; Li J; Li X; Yang X; Zhang S; Wang X; Wang N; Xu K; Jiang X; Zhang Y Front Genet; 2021; 12():676464. PubMed ID: 34194476 [TBL] [Abstract][Full Text] [Related]
20. A Novel Pyroptosis-Related Gene Signature for Early-Stage Lung Squamous Cell Carcinoma. Li X; He J Int J Gen Med; 2021; 14():6439-6453. PubMed ID: 34675612 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]